Diurnal Group: Edison Open House Healthcare 2022

Diurnal Group: Edison Open House Healthcare 2022

Diurnal Group — 2 videos in collection

Diurnal Group is a specialty pharma company developing new formulations of hormone-based products for the treatment of endocrine disorders.

• Tell us more about the company.
• Is it fair to say there is a high unmet need in this area, as many of the existing treatments are older?
• What is the market opportunity for your drug, Efmody, which was recently launched in the EU and UK?
• What is the importance of the natural rhythms of the body with regard to the dosing schedule for hormonal treatments?
• How big is the market opportunity?
• What are the plans for the development of Efmody in the US?
• Please tell us about your other products, Alkindi and DITEST?
• Which milestones should investors look out for in the coming year?


You may also be interested in these:

Healthcare

Diurnal Group - Edison Open House Interview

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.